Fagron, Inc. is a leading pharmaceutical compounding company specializing in the development and supply of products and services for creating personalized medications. It supports pharmacists, prescri... Fagron, Inc. is a leading pharmaceutical compounding company specializing in the development and supply of products and services for creating personalized medications. It supports pharmacists, prescribers, hospitals, and healthcare institutions by providing high-quality raw materials, semi-finished products, vehicles, packaging, laboratory equipment, and compounding software under its Essentials and Brands segments. Additionally, Fagron, Inc. offers sterile and non-sterile compounding services through outsourcing facilities, along with education via the Fagron Academy to advance professional development in pharmaceutical compounding. Operating as part of the global Fagron group with a strong U.S. presence, it adheres to FDA cGMP standards and serves over 150,000 customers across more than 30 countries. Key innovations include vehicles like Pentravan for transdermal delivery and SyrSpend for oral suspensions, addressing patient-specific needs such as allergies, unavailable dosages, or drug shortages. Through these offerings, Fagron, Inc. plays a vital role in enhancing medication accessibility, effectiveness, and safety in the healthcare sector, contributing to the broader shift toward personalized medicine.
Financial Fundamentals data not yet covered for Fagron
We have not yet reviewed Fagron's disclosures for Financial Fundamentals data.
If this data is relevant to your work, you can submit a data coverage request and our team
will investigate the company's disclosures and capture the data if available.